Grégoire Prevost

This inventor holds 14 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Ipsen Pharma S.a.s.. Active years: 2004-2014.

USPTO Granted Patents = 14 (Patent Applications = 2)

% Patents Active = 7.1

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

10 out of 119

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

Years Active: 2004-2014

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8624037 - Imidazolidine-2,4-dione derivatives and use thereof as a medicament (2014-01-07),

2. 8188133 - Imidazole derivatives, preparation and user thereof as medicine (2012-05-29),

3. 8017637 - Inhibitors of cdc phosphatases (2011-09-13),

4. 7795284 - 4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses (2010-09-14),

5. 7495021 - Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors (2009-02-24),

6. 7279467 - Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors (2007-10-09),

7. 7196084 - Cdc25 phosphatase inhibitors (2007-03-27),

8. 7132553 - Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension (2006-11-07),

9. 7091239 - DNA polymerase inhibitors, mikanolide and dihydromikanolide (2006-08-15),

10. 7034025 - Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein (2006-04-25),

11. 7034024 - Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment (2006-04-25),

12. 6887869 - Mikanolide derivatives, their preparation and therapeutic uses (2005-05-03),

13. 6846822 - Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension (2005-01-25),

14. 6767561 - DNA polymerase inhibitors, mikanolide and dihydromikanolide (2004-07-27),

Title: Grégoire Prevost: Pioneering Inventor from Antony, FR

Introduction: Grégoire Prevost is a renowned inventor hailing from Antony, France, known for his groundbreaking innovations in various fields.

Latest Patents: Grégoire Prevost holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials science.

Career Highlights: With a career spanning over two decades, Grégoire Prevost has been instrumental in developing cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Grégoire Prevost has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life and make a lasting impact on society.

Conclusion: Grégoire Prevost's passion for innovation and his dedication to creating a sustainable future through his inventions make him a true visionary in the world of technology and science.